Saturday, Jun 24th

Last update:09:00:00 AM GMT

You are here: Health Medicine Tylenol Makes Lower Doses
To reduce the risk of accidental overdose from acetaminophen, an active ingredient found in over 600 over-the-counter medicines, the manufacturer of Tylenol has released a new lower dosing instruction.

McNeil Consumer Healthcare, a division of Johnson & Johnson, now recommends the maximum dosage for extra strength Tylenol to be six pills a day – as opposed to eight – for a total of 3,000 mg. The new labels will appear on Tylenol products starting in the fall, and changes to the maximum dosage of regular strength Tylenol and its other products will begin in 2012.

“Some people accidentally exceed the recommended dose when taking multiple products at the same time, often without realizing they contain acetaminophen or by not reading and following the dosing instructions,” Dr. Edwin Kuffner, vice president of OTC Medical Affairs and Clinical Research at McNeil Consumer Healthcare, told CNN. “McNeil is revising its labels for products containing acetaminophen in an attempt to decrease the likelihood of accidental overdosing in those instances.”

Kuffner contends that acetaminophen is safe when used as directed, although it can cause liver damage if misused. The U.S. Food and Drug Administration began an effort in January to reduce the risk of liver damage by asking companies that make products with acetaminophen to limit the amount of the drug per pill to 325 mg and have a clear warning on all packaging.

We recommend:
Harvard Scientist Says Improved Treatment Coming for COPD
Chronic obstructive pulmonary disease (COPD) takes an enormous toll in human suffering and medical
8 simple steps to help seniors, caregivers better manage medications
Modern medicine can work wonders. However, in order to be effective, medicine needs to be taken saf
Taking a leading role in type 2 diabetes management
A veteran of both screen and stage, legendary actor James Earl Jones is well known for playing icon
Charlie Sheen on the Brink
Recently, Nader Pourhassan, PhD, and CEO of CytoDyn, appeared on the “Dr. Oz Show” with actor C